The British bootmaker Dr Martens has reaffirmed its fiscal 2027 outlook, buoyed by a recovery in wholesale demand from its largest market, the United States.
The company announced the decision on Wednesday, pointing to encouraging orders from American retailers. A pair of Dr Martens boots seen through the window of a London store illustrates the brand’s enduring presence, and the company is betting that US consumers will continue to drive sales.
“Dr Martens backs fiscal 2027 outlook citing encouraging US wholesale demand.”
The reaffirmation comes as the brand navigates a challenging retail landscape, but the vote of confidence signals that the worst of the slowdown may be past.
Advertisement